BTC $64,964.18 +0.74%
ETH $1,927.88 +1.26%
BNB $587.41 +3.34%
XRP $1.08 +1.22%
SOL $74.65 +1.60%
TRX $0.3280 +0.45%
DOGE $0.0703 -0.28%
ADA $0.1680 +2.00%
BCH $220.49 +4.76%
LINK $8.51 +2.25%
HYPE $53.42 -3.15%
AAVE $99.38 +1.15%
SUI $0.6962 +1.31%
XLM $0.1731 -0.61%
ZEC $476.24 +2.17%
BTC $64,964.18 +0.74%
ETH $1,927.88 +1.26%
BNB $587.41 +3.34%
XRP $1.08 +1.22%
SOL $74.65 +1.60%
TRX $0.3280 +0.45%
DOGE $0.0703 -0.28%
ADA $0.1680 +2.00%
BCH $220.49 +4.76%
LINK $8.51 +2.25%
HYPE $53.42 -3.15%
AAVE $99.38 +1.15%
SUI $0.6962 +1.31%
XLM $0.1731 -0.61%
ZEC $476.24 +2.17%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01
Collection

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.